nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—PTGS1—kidney cancer	0.377	1	CbGaD
Diphenhydramine—SLC22A5—Dactinomycin—kidney cancer	0.0832	0.199	CbGbCtD
Diphenhydramine—SLC22A2—Vinblastine—kidney cancer	0.0497	0.119	CbGbCtD
Diphenhydramine—CYP2D6—Temsirolimus—kidney cancer	0.0414	0.0992	CbGbCtD
Diphenhydramine—CYP1A2—Pazopanib—kidney cancer	0.0264	0.0632	CbGbCtD
Diphenhydramine—CYP2B6—Sorafenib—kidney cancer	0.0261	0.0626	CbGbCtD
Diphenhydramine—CYP2C9—Capecitabine—kidney cancer	0.0248	0.0594	CbGbCtD
Diphenhydramine—CYP2D6—Pazopanib—kidney cancer	0.0218	0.0521	CbGbCtD
Diphenhydramine—CYP1A2—Erlotinib—kidney cancer	0.0189	0.0451	CbGbCtD
Diphenhydramine—CYP2C19—Sorafenib—kidney cancer	0.0166	0.0398	CbGbCtD
Diphenhydramine—CYP2B6—Doxorubicin—kidney cancer	0.0159	0.038	CbGbCtD
Diphenhydramine—CYP2C9—Paclitaxel—kidney cancer	0.0155	0.0372	CbGbCtD
Diphenhydramine—CYP2D6—Erlotinib—kidney cancer	0.0155	0.0372	CbGbCtD
Diphenhydramine—CYP1A2—Sorafenib—kidney cancer	0.0153	0.0367	CbGbCtD
Diphenhydramine—CYP2C9—Sorafenib—kidney cancer	0.0138	0.033	CbGbCtD
Diphenhydramine—CYP2D6—Sorafenib—kidney cancer	0.0126	0.0302	CbGbCtD
Diphenhydramine—CYP2D6—Vinblastine—kidney cancer	0.0125	0.0298	CbGbCtD
Diphenhydramine—SLC22A2—nephron—kidney cancer	0.00801	0.214	CbGeAlD
Diphenhydramine—CYP2D6—Doxorubicin—kidney cancer	0.00766	0.0183	CbGbCtD
Diphenhydramine—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00351	1	CbGdCrCtD
Diphenhydramine—CYP2C19—urine—kidney cancer	0.0035	0.0934	CbGeAlD
Diphenhydramine—CYP1A2—urine—kidney cancer	0.00286	0.0763	CbGeAlD
Diphenhydramine—CYP2C9—urine—kidney cancer	0.00271	0.0724	CbGeAlD
Diphenhydramine—CYP2D6—urine—kidney cancer	0.00203	0.0543	CbGeAlD
Diphenhydramine—SLC22A2—nephron tubule—kidney cancer	0.00173	0.0462	CbGeAlD
Diphenhydramine—SLC22A2—renal system—kidney cancer	0.00157	0.042	CbGeAlD
Diphenhydramine—SLC22A2—kidney—kidney cancer	0.00152	0.0406	CbGeAlD
Diphenhydramine—SLC22A2—cortex of kidney—kidney cancer	0.00148	0.0395	CbGeAlD
Diphenhydramine—SLC22A1—renal system—kidney cancer	0.00111	0.0296	CbGeAlD
Diphenhydramine—SLC22A1—kidney—kidney cancer	0.00107	0.0287	CbGeAlD
Diphenhydramine—SLC22A5—nephron tubule—kidney cancer	0.000849	0.0227	CbGeAlD
Diphenhydramine—SLC22A5—renal system—kidney cancer	0.000772	0.0206	CbGeAlD
Diphenhydramine—SLC22A5—kidney—kidney cancer	0.000746	0.0199	CbGeAlD
Diphenhydramine—CYP2B6—nephron tubule—kidney cancer	0.000737	0.0197	CbGeAlD
Diphenhydramine—Dimetacrine—ACHE—kidney cancer	0.000735	0.178	CrCbGaD
Diphenhydramine—SLC22A5—cortex of kidney—kidney cancer	0.000726	0.0194	CbGeAlD
Diphenhydramine—CYP1A2—renal system—kidney cancer	0.000699	0.0187	CbGeAlD
Diphenhydramine—SLC22A5—cardiac atrium—kidney cancer	0.000691	0.0185	CbGeAlD
Diphenhydramine—CYP2B6—renal system—kidney cancer	0.00067	0.0179	CbGeAlD
Diphenhydramine—CYP2B6—kidney—kidney cancer	0.000648	0.0173	CbGeAlD
Diphenhydramine—PTGS1—renal system—kidney cancer	0.000606	0.0162	CbGeAlD
Diphenhydramine—CYP2B6—gonad—kidney cancer	0.000601	0.016	CbGeAlD
Diphenhydramine—PTGS1—kidney—kidney cancer	0.000586	0.0156	CbGeAlD
Diphenhydramine—PTGS1—cardiac atrium—kidney cancer	0.000542	0.0145	CbGeAlD
Diphenhydramine—CYP2D6—renal system—kidney cancer	0.000498	0.0133	CbGeAlD
Diphenhydramine—CYP2D6—kidney—kidney cancer	0.000481	0.0129	CbGeAlD
Diphenhydramine—Cyclopentolate—BCHE—kidney cancer	0.000423	0.102	CrCbGaD
Diphenhydramine—Pollakiuria—Paclitaxel—kidney cancer	0.000392	0.00346	CcSEcCtD
Diphenhydramine—Asthenia—Pazopanib—kidney cancer	0.000391	0.00345	CcSEcCtD
Diphenhydramine—Insomnia—Everolimus—kidney cancer	0.000389	0.00343	CcSEcCtD
Diphenhydramine—Paraesthesia—Vinblastine—kidney cancer	0.000388	0.00342	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Paclitaxel—kidney cancer	0.000387	0.00341	CcSEcCtD
Diphenhydramine—Paraesthesia—Everolimus—kidney cancer	0.000386	0.0034	CcSEcCtD
Diphenhydramine—Irritability—Capecitabine—kidney cancer	0.000385	0.00339	CcSEcCtD
Diphenhydramine—Urinary retention—Capecitabine—kidney cancer	0.000383	0.00338	CcSEcCtD
Diphenhydramine—Somnolence—Everolimus—kidney cancer	0.000382	0.00337	CcSEcCtD
Diphenhydramine—Dizziness—Temsirolimus—kidney cancer	0.000382	0.00337	CcSEcCtD
Diphenhydramine—Convulsion—Sunitinib—kidney cancer	0.000381	0.00336	CcSEcCtD
Diphenhydramine—Dry mouth—Sorafenib—kidney cancer	0.000381	0.00336	CcSEcCtD
Diphenhydramine—Dyspepsia—Everolimus—kidney cancer	0.000379	0.00334	CcSEcCtD
Diphenhydramine—Insomnia—Erlotinib—kidney cancer	0.000375	0.00331	CcSEcCtD
Diphenhydramine—Decreased appetite—Vinblastine—kidney cancer	0.000375	0.00331	CcSEcCtD
Diphenhydramine—Decreased appetite—Everolimus—kidney cancer	0.000374	0.0033	CcSEcCtD
Diphenhydramine—Diarrhoea—Pazopanib—kidney cancer	0.000373	0.00329	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Paclitaxel—kidney cancer	0.000371	0.00327	CcSEcCtD
Diphenhydramine—Fatigue—Everolimus—kidney cancer	0.000371	0.00327	CcSEcCtD
Diphenhydramine—Constipation—Vinblastine—kidney cancer	0.000369	0.00325	CcSEcCtD
Diphenhydramine—Constipation—Everolimus—kidney cancer	0.000368	0.00324	CcSEcCtD
Diphenhydramine—Vomiting—Temsirolimus—kidney cancer	0.000368	0.00324	CcSEcCtD
Diphenhydramine—Dry mouth—Sunitinib—kidney cancer	0.000367	0.00323	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Sorafenib—kidney cancer	0.000366	0.00322	CcSEcCtD
Diphenhydramine—Dyspepsia—Erlotinib—kidney cancer	0.000365	0.00322	CcSEcCtD
Diphenhydramine—Rash—Temsirolimus—kidney cancer	0.000365	0.00321	CcSEcCtD
Diphenhydramine—Dermatitis—Temsirolimus—kidney cancer	0.000364	0.00321	CcSEcCtD
Diphenhydramine—Chills—Gemcitabine—kidney cancer	0.000364	0.00321	CcSEcCtD
Diphenhydramine—Headache—Temsirolimus—kidney cancer	0.000362	0.00319	CcSEcCtD
Diphenhydramine—Decreased appetite—Erlotinib—kidney cancer	0.000361	0.00318	CcSEcCtD
Diphenhydramine—Dizziness—Pazopanib—kidney cancer	0.00036	0.00318	CcSEcCtD
Diphenhydramine—Fatigue—Erlotinib—kidney cancer	0.000358	0.00315	CcSEcCtD
Diphenhydramine—Anorexia—Sorafenib—kidney cancer	0.000356	0.00314	CcSEcCtD
Diphenhydramine—Feeling abnormal—Vinblastine—kidney cancer	0.000356	0.00314	CcSEcCtD
Diphenhydramine—Constipation—Erlotinib—kidney cancer	0.000355	0.00313	CcSEcCtD
Diphenhydramine—Feeling abnormal—Everolimus—kidney cancer	0.000354	0.00312	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Sunitinib—kidney cancer	0.000352	0.0031	CcSEcCtD
Diphenhydramine—Vomiting—Pazopanib—kidney cancer	0.000346	0.00305	CcSEcCtD
Diphenhydramine—Rash—Pazopanib—kidney cancer	0.000344	0.00303	CcSEcCtD
Diphenhydramine—Nausea—Temsirolimus—kidney cancer	0.000344	0.00303	CcSEcCtD
Diphenhydramine—Dermatitis—Pazopanib—kidney cancer	0.000343	0.00302	CcSEcCtD
Diphenhydramine—Anorexia—Sunitinib—kidney cancer	0.000342	0.00302	CcSEcCtD
Diphenhydramine—Agitation—Vincristine—kidney cancer	0.000342	0.00302	CcSEcCtD
Diphenhydramine—Headache—Pazopanib—kidney cancer	0.000341	0.00301	CcSEcCtD
Diphenhydramine—Sweating increased—Capecitabine—kidney cancer	0.000339	0.00299	CcSEcCtD
Diphenhydramine—Vertigo—Vincristine—kidney cancer	0.000335	0.00295	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Dactinomycin—kidney cancer	0.000333	0.00294	CcSEcCtD
Diphenhydramine—Dyspepsia—Sorafenib—kidney cancer	0.000329	0.0029	CcSEcCtD
Diphenhydramine—Dysuria—Capecitabine—kidney cancer	0.000326	0.00287	CcSEcCtD
Diphenhydramine—Insomnia—Sunitinib—kidney cancer	0.000325	0.00286	CcSEcCtD
Diphenhydramine—Decreased appetite—Sorafenib—kidney cancer	0.000325	0.00286	CcSEcCtD
Diphenhydramine—Anorexia—Dactinomycin—kidney cancer	0.000324	0.00286	CcSEcCtD
Diphenhydramine—Nausea—Pazopanib—kidney cancer	0.000324	0.00285	CcSEcCtD
Diphenhydramine—Paraesthesia—Sunitinib—kidney cancer	0.000323	0.00284	CcSEcCtD
Diphenhydramine—Convulsion—Vincristine—kidney cancer	0.000323	0.00284	CcSEcCtD
Diphenhydramine—Fatigue—Sorafenib—kidney cancer	0.000322	0.00284	CcSEcCtD
Diphenhydramine—Constipation—Sorafenib—kidney cancer	0.000319	0.00281	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Capecitabine—kidney cancer	0.000318	0.0028	CcSEcCtD
Diphenhydramine—Tinnitus—Paclitaxel—kidney cancer	0.000317	0.00279	CcSEcCtD
Diphenhydramine—Dyspepsia—Sunitinib—kidney cancer	0.000316	0.00279	CcSEcCtD
Diphenhydramine—Decreased appetite—Sunitinib—kidney cancer	0.000312	0.00275	CcSEcCtD
Diphenhydramine—Asthenia—Vinblastine—kidney cancer	0.00031	0.00273	CcSEcCtD
Diphenhydramine—Fatigue—Sunitinib—kidney cancer	0.00031	0.00273	CcSEcCtD
Diphenhydramine—Asthenia—Everolimus—kidney cancer	0.000309	0.00272	CcSEcCtD
Diphenhydramine—Constipation—Sunitinib—kidney cancer	0.000307	0.00271	CcSEcCtD
Diphenhydramine—Chills—Paclitaxel—kidney cancer	0.000305	0.00269	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Capecitabine—kidney cancer	0.000304	0.00268	CcSEcCtD
Diphenhydramine—Oxaprozin—PTGS1—kidney cancer	0.0003	0.0724	CrCbGaD
Diphenhydramine—Asthenia—Erlotinib—kidney cancer	0.000298	0.00262	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Vincristine—kidney cancer	0.000298	0.00262	CcSEcCtD
Diphenhydramine—Urticaria—Sorafenib—kidney cancer	0.000297	0.00261	CcSEcCtD
Diphenhydramine—Photosensitivity—Doxorubicin—kidney cancer	0.000296	0.00261	CcSEcCtD
Diphenhydramine—Decreased appetite—Dactinomycin—kidney cancer	0.000296	0.00261	CcSEcCtD
Diphenhydramine—Diarrhoea—Vinblastine—kidney cancer	0.000295	0.0026	CcSEcCtD
Diphenhydramine—Diarrhoea—Everolimus—kidney cancer	0.000294	0.00259	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Vincristine—kidney cancer	0.000294	0.00259	CcSEcCtD
Diphenhydramine—Fatigue—Dactinomycin—kidney cancer	0.000293	0.00258	CcSEcCtD
Diphenhydramine—Tension—Paclitaxel—kidney cancer	0.00029	0.00256	CcSEcCtD
Diphenhydramine—Agranulocytosis—Capecitabine—kidney cancer	0.00029	0.00255	CcSEcCtD
Diphenhydramine—Anorexia—Vincristine—kidney cancer	0.00029	0.00255	CcSEcCtD
Diphenhydramine—Nervousness—Paclitaxel—kidney cancer	0.000287	0.00253	CcSEcCtD
Diphenhydramine—Dizziness—Vinblastine—kidney cancer	0.000286	0.00252	CcSEcCtD
Diphenhydramine—Dizziness—Everolimus—kidney cancer	0.000284	0.00251	CcSEcCtD
Diphenhydramine—Diarrhoea—Erlotinib—kidney cancer	0.000284	0.0025	CcSEcCtD
Diphenhydramine—Hypotension—Vincristine—kidney cancer	0.000284	0.0025	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000282	0.00249	CcSEcCtD
Diphenhydramine—Feeling abnormal—Dactinomycin—kidney cancer	0.00028	0.00247	CcSEcCtD
Diphenhydramine—Vision blurred—Paclitaxel—kidney cancer	0.000279	0.00246	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000279	0.00246	CcSEcCtD
Diphenhydramine—Tremor—Paclitaxel—kidney cancer	0.000277	0.00244	CcSEcCtD
Diphenhydramine—Insomnia—Vincristine—kidney cancer	0.000275	0.00242	CcSEcCtD
Diphenhydramine—Anorexia—Gemcitabine—kidney cancer	0.000275	0.00242	CcSEcCtD
Diphenhydramine—Vomiting—Vinblastine—kidney cancer	0.000275	0.00242	CcSEcCtD
Diphenhydramine—Dizziness—Erlotinib—kidney cancer	0.000274	0.00242	CcSEcCtD
Diphenhydramine—Vomiting—Everolimus—kidney cancer	0.000274	0.00241	CcSEcCtD
Diphenhydramine—Paraesthesia—Vincristine—kidney cancer	0.000273	0.00241	CcSEcCtD
Diphenhydramine—Agitation—Paclitaxel—kidney cancer	0.000272	0.0024	CcSEcCtD
Diphenhydramine—Rash—Everolimus—kidney cancer	0.000271	0.00239	CcSEcCtD
Diphenhydramine—Dermatitis—Everolimus—kidney cancer	0.000271	0.00239	CcSEcCtD
Diphenhydramine—Headache—Vinblastine—kidney cancer	0.000271	0.00238	CcSEcCtD
Diphenhydramine—Headache—Everolimus—kidney cancer	0.000269	0.00238	CcSEcCtD
Diphenhydramine—Hypotension—Gemcitabine—kidney cancer	0.000269	0.00237	CcSEcCtD
Diphenhydramine—Asthenia—Sorafenib—kidney cancer	0.000268	0.00236	CcSEcCtD
Diphenhydramine—Vertigo—Paclitaxel—kidney cancer	0.000266	0.00234	CcSEcCtD
Diphenhydramine—Decreased appetite—Vincristine—kidney cancer	0.000264	0.00233	CcSEcCtD
Diphenhydramine—Vomiting—Erlotinib—kidney cancer	0.000264	0.00233	CcSEcCtD
Diphenhydramine—Fatigue—Vincristine—kidney cancer	0.000262	0.00231	CcSEcCtD
Diphenhydramine—Rash—Erlotinib—kidney cancer	0.000262	0.00231	CcSEcCtD
Diphenhydramine—Dermatitis—Erlotinib—kidney cancer	0.000261	0.0023	CcSEcCtD
Diphenhydramine—Palpitations—Paclitaxel—kidney cancer	0.000261	0.0023	CcSEcCtD
Diphenhydramine—Insomnia—Gemcitabine—kidney cancer	0.000261	0.0023	CcSEcCtD
Diphenhydramine—Headache—Erlotinib—kidney cancer	0.00026	0.00229	CcSEcCtD
Diphenhydramine—Tinnitus—Capecitabine—kidney cancer	0.00026	0.00229	CcSEcCtD
Diphenhydramine—Constipation—Vincristine—kidney cancer	0.00026	0.00229	CcSEcCtD
Diphenhydramine—Diplopia—Doxorubicin—kidney cancer	0.00026	0.00229	CcSEcCtD
Diphenhydramine—Paraesthesia—Gemcitabine—kidney cancer	0.000259	0.00228	CcSEcCtD
Diphenhydramine—Asthenia—Sunitinib—kidney cancer	0.000258	0.00227	CcSEcCtD
Diphenhydramine—Nausea—Vinblastine—kidney cancer	0.000257	0.00226	CcSEcCtD
Diphenhydramine—Somnolence—Gemcitabine—kidney cancer	0.000256	0.00226	CcSEcCtD
Diphenhydramine—Convulsion—Paclitaxel—kidney cancer	0.000256	0.00226	CcSEcCtD
Diphenhydramine—Nausea—Everolimus—kidney cancer	0.000256	0.00225	CcSEcCtD
Diphenhydramine—Diarrhoea—Sorafenib—kidney cancer	0.000255	0.00225	CcSEcCtD
Diphenhydramine—Decreased appetite—Gemcitabine—kidney cancer	0.000251	0.00221	CcSEcCtD
Diphenhydramine—Chills—Capecitabine—kidney cancer	0.00025	0.0022	CcSEcCtD
Diphenhydramine—Fatigue—Gemcitabine—kidney cancer	0.000249	0.00219	CcSEcCtD
Diphenhydramine—Fenoprofen—PTGS1—kidney cancer	0.000248	0.0598	CrCbGaD
Diphenhydramine—Dizziness—Sorafenib—kidney cancer	0.000247	0.00218	CcSEcCtD
Diphenhydramine—Constipation—Gemcitabine—kidney cancer	0.000247	0.00217	CcSEcCtD
Diphenhydramine—Nausea—Erlotinib—kidney cancer	0.000247	0.00217	CcSEcCtD
Diphenhydramine—Dry mouth—Paclitaxel—kidney cancer	0.000246	0.00217	CcSEcCtD
Diphenhydramine—Diarrhoea—Sunitinib—kidney cancer	0.000246	0.00217	CcSEcCtD
Diphenhydramine—Asthenia—Dactinomycin—kidney cancer	0.000244	0.00215	CcSEcCtD
Diphenhydramine—Confusional state—Paclitaxel—kidney cancer	0.000243	0.00215	CcSEcCtD
Diphenhydramine—Toremifene—CYP1A1—kidney cancer	0.00024	0.058	CrCbGaD
Diphenhydramine—Dizziness—Sunitinib—kidney cancer	0.000238	0.00209	CcSEcCtD
Diphenhydramine—Feeling abnormal—Gemcitabine—kidney cancer	0.000238	0.00209	CcSEcCtD
Diphenhydramine—Vomiting—Sorafenib—kidney cancer	0.000237	0.00209	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000236	0.00208	CcSEcCtD
Diphenhydramine—Tachycardia—Paclitaxel—kidney cancer	0.000236	0.00208	CcSEcCtD
Diphenhydramine—Rash—Sorafenib—kidney cancer	0.000235	0.00208	CcSEcCtD
Diphenhydramine—Dermatitis—Sorafenib—kidney cancer	0.000235	0.00207	CcSEcCtD
Diphenhydramine—Headache—Sorafenib—kidney cancer	0.000234	0.00206	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000233	0.00206	CcSEcCtD
Diphenhydramine—Diarrhoea—Dactinomycin—kidney cancer	0.000233	0.00205	CcSEcCtD
Diphenhydramine—Anorexia—Paclitaxel—kidney cancer	0.00023	0.00203	CcSEcCtD
Diphenhydramine—Vision blurred—Capecitabine—kidney cancer	0.000229	0.00202	CcSEcCtD
Diphenhydramine—Vomiting—Sunitinib—kidney cancer	0.000228	0.00201	CcSEcCtD
Diphenhydramine—Tremor—Capecitabine—kidney cancer	0.000227	0.002	CcSEcCtD
Diphenhydramine—Rash—Sunitinib—kidney cancer	0.000227	0.002	CcSEcCtD
Diphenhydramine—Dermatitis—Sunitinib—kidney cancer	0.000226	0.00199	CcSEcCtD
Diphenhydramine—Hypotension—Paclitaxel—kidney cancer	0.000226	0.00199	CcSEcCtD
Diphenhydramine—Headache—Sunitinib—kidney cancer	0.000225	0.00198	CcSEcCtD
Diphenhydramine—Nausea—Sorafenib—kidney cancer	0.000222	0.00195	CcSEcCtD
Diphenhydramine—Insomnia—Paclitaxel—kidney cancer	0.000218	0.00192	CcSEcCtD
Diphenhydramine—Vertigo—Capecitabine—kidney cancer	0.000218	0.00192	CcSEcCtD
Diphenhydramine—Asthenia—Vincristine—kidney cancer	0.000218	0.00192	CcSEcCtD
Diphenhydramine—Paraesthesia—Paclitaxel—kidney cancer	0.000217	0.00191	CcSEcCtD
Diphenhydramine—Vomiting—Dactinomycin—kidney cancer	0.000216	0.00191	CcSEcCtD
Diphenhydramine—Somnolence—Paclitaxel—kidney cancer	0.000215	0.00189	CcSEcCtD
Diphenhydramine—Palpitations—Capecitabine—kidney cancer	0.000214	0.00189	CcSEcCtD
Diphenhydramine—Rash—Dactinomycin—kidney cancer	0.000214	0.00189	CcSEcCtD
Diphenhydramine—Nausea—Sunitinib—kidney cancer	0.000213	0.00188	CcSEcCtD
Diphenhydramine—Dyspepsia—Paclitaxel—kidney cancer	0.000212	0.00187	CcSEcCtD
Diphenhydramine—Dysuria—Doxorubicin—kidney cancer	0.00021	0.00185	CcSEcCtD
Diphenhydramine—Decreased appetite—Paclitaxel—kidney cancer	0.00021	0.00185	CcSEcCtD
Diphenhydramine—Fatigue—Paclitaxel—kidney cancer	0.000208	0.00183	CcSEcCtD
Diphenhydramine—Diarrhoea—Vincristine—kidney cancer	0.000208	0.00183	CcSEcCtD
Diphenhydramine—Clomifene—CYP1A1—kidney cancer	0.000208	0.0502	CrCbGaD
Diphenhydramine—Pollakiuria—Doxorubicin—kidney cancer	0.000207	0.00183	CcSEcCtD
Diphenhydramine—Asthenia—Gemcitabine—kidney cancer	0.000207	0.00182	CcSEcCtD
Diphenhydramine—Constipation—Paclitaxel—kidney cancer	0.000206	0.00182	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000205	0.00181	CcSEcCtD
Diphenhydramine—Dry mouth—Capecitabine—kidney cancer	0.000202	0.00178	CcSEcCtD
Diphenhydramine—Nausea—Dactinomycin—kidney cancer	0.000202	0.00178	CcSEcCtD
Diphenhydramine—Dizziness—Vincristine—kidney cancer	0.000201	0.00177	CcSEcCtD
Diphenhydramine—Drowsiness—Doxorubicin—kidney cancer	0.0002	0.00176	CcSEcCtD
Diphenhydramine—Confusional state—Capecitabine—kidney cancer	0.0002	0.00176	CcSEcCtD
Diphenhydramine—Feeling abnormal—Paclitaxel—kidney cancer	0.000199	0.00175	CcSEcCtD
Diphenhydramine—Phenylbutazone—PTGS1—kidney cancer	0.000198	0.0478	CrCbGaD
Diphenhydramine—Diarrhoea—Gemcitabine—kidney cancer	0.000197	0.00174	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000196	0.00173	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Capecitabine—kidney cancer	0.000194	0.00171	CcSEcCtD
Diphenhydramine—Tachycardia—Capecitabine—kidney cancer	0.000193	0.0017	CcSEcCtD
Diphenhydramine—Vomiting—Vincristine—kidney cancer	0.000193	0.0017	CcSEcCtD
Diphenhydramine—Urticaria—Paclitaxel—kidney cancer	0.000192	0.00169	CcSEcCtD
Diphenhydramine—Rash—Vincristine—kidney cancer	0.000192	0.00169	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Capecitabine—kidney cancer	0.000191	0.00169	CcSEcCtD
Diphenhydramine—Dermatitis—Vincristine—kidney cancer	0.000191	0.00169	CcSEcCtD
Diphenhydramine—Headache—Vincristine—kidney cancer	0.00019	0.00168	CcSEcCtD
Diphenhydramine—Anorexia—Capecitabine—kidney cancer	0.000189	0.00166	CcSEcCtD
Diphenhydramine—Agranulocytosis—Doxorubicin—kidney cancer	0.000187	0.00165	CcSEcCtD
Diphenhydramine—Hypotension—Capecitabine—kidney cancer	0.000185	0.00163	CcSEcCtD
Diphenhydramine—Vomiting—Gemcitabine—kidney cancer	0.000183	0.00162	CcSEcCtD
Diphenhydramine—Rash—Gemcitabine—kidney cancer	0.000182	0.0016	CcSEcCtD
Diphenhydramine—Dermatitis—Gemcitabine—kidney cancer	0.000182	0.0016	CcSEcCtD
Diphenhydramine—Headache—Gemcitabine—kidney cancer	0.000181	0.00159	CcSEcCtD
Diphenhydramine—Nausea—Vincristine—kidney cancer	0.000181	0.00159	CcSEcCtD
Diphenhydramine—Insomnia—Capecitabine—kidney cancer	0.000179	0.00158	CcSEcCtD
Diphenhydramine—Paraesthesia—Capecitabine—kidney cancer	0.000178	0.00157	CcSEcCtD
Diphenhydramine—Dyspepsia—Capecitabine—kidney cancer	0.000174	0.00154	CcSEcCtD
Diphenhydramine—Asthenia—Paclitaxel—kidney cancer	0.000173	0.00153	CcSEcCtD
Diphenhydramine—Warfarin—CYP1A1—kidney cancer	0.000173	0.0418	CrCbGaD
Diphenhydramine—Decreased appetite—Capecitabine—kidney cancer	0.000172	0.00152	CcSEcCtD
Diphenhydramine—Nausea—Gemcitabine—kidney cancer	0.000171	0.00151	CcSEcCtD
Diphenhydramine—Oxaprozin—PTGS2—kidney cancer	0.000171	0.0414	CrCbGaD
Diphenhydramine—Fatigue—Capecitabine—kidney cancer	0.000171	0.00151	CcSEcCtD
Diphenhydramine—Constipation—Capecitabine—kidney cancer	0.000169	0.00149	CcSEcCtD
Diphenhydramine—Tinnitus—Doxorubicin—kidney cancer	0.000168	0.00148	CcSEcCtD
Diphenhydramine—Diarrhoea—Paclitaxel—kidney cancer	0.000165	0.00146	CcSEcCtD
Diphenhydramine—Feeling abnormal—Capecitabine—kidney cancer	0.000163	0.00144	CcSEcCtD
Diphenhydramine—Chills—Doxorubicin—kidney cancer	0.000161	0.00142	CcSEcCtD
Diphenhydramine—Reboxetine—ABCB1—kidney cancer	0.000161	0.0389	CrCbGaD
Diphenhydramine—Dizziness—Paclitaxel—kidney cancer	0.00016	0.00141	CcSEcCtD
Diphenhydramine—Urticaria—Capecitabine—kidney cancer	0.000157	0.00139	CcSEcCtD
Diphenhydramine—Tension—Doxorubicin—kidney cancer	0.000154	0.00135	CcSEcCtD
Diphenhydramine—Vomiting—Paclitaxel—kidney cancer	0.000153	0.00135	CcSEcCtD
Diphenhydramine—Rash—Paclitaxel—kidney cancer	0.000152	0.00134	CcSEcCtD
Diphenhydramine—Dermatitis—Paclitaxel—kidney cancer	0.000152	0.00134	CcSEcCtD
Diphenhydramine—Nervousness—Doxorubicin—kidney cancer	0.000152	0.00134	CcSEcCtD
Diphenhydramine—Headache—Paclitaxel—kidney cancer	0.000151	0.00133	CcSEcCtD
Diphenhydramine—Vision blurred—Doxorubicin—kidney cancer	0.000147	0.0013	CcSEcCtD
Diphenhydramine—Agitation—Doxorubicin—kidney cancer	0.000144	0.00127	CcSEcCtD
Diphenhydramine—Nausea—Paclitaxel—kidney cancer	0.000143	0.00126	CcSEcCtD
Diphenhydramine—Asthenia—Capecitabine—kidney cancer	0.000142	0.00125	CcSEcCtD
Diphenhydramine—Fenoprofen—PTGS2—kidney cancer	0.000141	0.0342	CrCbGaD
Diphenhydramine—Vertigo—Doxorubicin—kidney cancer	0.000141	0.00124	CcSEcCtD
Diphenhydramine—Palpitations—Doxorubicin—kidney cancer	0.000138	0.00122	CcSEcCtD
Diphenhydramine—Cinnarizine—CYP1A1—kidney cancer	0.000137	0.0332	CrCbGaD
Diphenhydramine—Convulsion—Doxorubicin—kidney cancer	0.000136	0.00119	CcSEcCtD
Diphenhydramine—Diarrhoea—Capecitabine—kidney cancer	0.000136	0.00119	CcSEcCtD
Diphenhydramine—Dizziness—Capecitabine—kidney cancer	0.000131	0.00115	CcSEcCtD
Diphenhydramine—Dry mouth—Doxorubicin—kidney cancer	0.00013	0.00115	CcSEcCtD
Diphenhydramine—Confusional state—Doxorubicin—kidney cancer	0.000129	0.00113	CcSEcCtD
Diphenhydramine—Toremifene—ABCB1—kidney cancer	0.000128	0.0308	CrCbGaD
Diphenhydramine—Vomiting—Capecitabine—kidney cancer	0.000126	0.00111	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Doxorubicin—kidney cancer	0.000125	0.0011	CcSEcCtD
Diphenhydramine—Rash—Capecitabine—kidney cancer	0.000125	0.0011	CcSEcCtD
Diphenhydramine—Dermatitis—Capecitabine—kidney cancer	0.000125	0.0011	CcSEcCtD
Diphenhydramine—Tachycardia—Doxorubicin—kidney cancer	0.000125	0.0011	CcSEcCtD
Diphenhydramine—Headache—Capecitabine—kidney cancer	0.000124	0.00109	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000123	0.00109	CcSEcCtD
Diphenhydramine—Anorexia—Doxorubicin—kidney cancer	0.000122	0.00107	CcSEcCtD
Diphenhydramine—Hypotension—Doxorubicin—kidney cancer	0.000119	0.00105	CcSEcCtD
Diphenhydramine—Nausea—Capecitabine—kidney cancer	0.000118	0.00104	CcSEcCtD
Diphenhydramine—Insomnia—Doxorubicin—kidney cancer	0.000115	0.00102	CcSEcCtD
Diphenhydramine—Paraesthesia—Doxorubicin—kidney cancer	0.000115	0.00101	CcSEcCtD
Diphenhydramine—Somnolence—Doxorubicin—kidney cancer	0.000114	0.001	CcSEcCtD
Diphenhydramine—Phenylbutazone—PTGS2—kidney cancer	0.000113	0.0273	CrCbGaD
Diphenhydramine—Dyspepsia—Doxorubicin—kidney cancer	0.000112	0.000991	CcSEcCtD
Diphenhydramine—Decreased appetite—Doxorubicin—kidney cancer	0.000111	0.000978	CcSEcCtD
Diphenhydramine—Clomifene—ABCB1—kidney cancer	0.00011	0.0267	CrCbGaD
Diphenhydramine—Fatigue—Doxorubicin—kidney cancer	0.00011	0.00097	CcSEcCtD
Diphenhydramine—Constipation—Doxorubicin—kidney cancer	0.000109	0.000962	CcSEcCtD
Diphenhydramine—Feeling abnormal—Doxorubicin—kidney cancer	0.000105	0.000927	CcSEcCtD
Diphenhydramine—Urticaria—Doxorubicin—kidney cancer	0.000101	0.000894	CcSEcCtD
Diphenhydramine—Tamoxifen—CYP1A1—kidney cancer	9.59e-05	0.0232	CrCbGaD
Diphenhydramine—Asthenia—Doxorubicin—kidney cancer	9.16e-05	0.000807	CcSEcCtD
Diphenhydramine—Diarrhoea—Doxorubicin—kidney cancer	8.74e-05	0.00077	CcSEcCtD
Diphenhydramine—Dizziness—Doxorubicin—kidney cancer	8.44e-05	0.000744	CcSEcCtD
Diphenhydramine—Vomiting—Doxorubicin—kidney cancer	8.12e-05	0.000716	CcSEcCtD
Diphenhydramine—Rash—Doxorubicin—kidney cancer	8.05e-05	0.00071	CcSEcCtD
Diphenhydramine—Dermatitis—Doxorubicin—kidney cancer	8.04e-05	0.000709	CcSEcCtD
Diphenhydramine—Bepridil—ABCB1—kidney cancer	8.02e-05	0.0194	CrCbGaD
Diphenhydramine—Headache—Doxorubicin—kidney cancer	8e-05	0.000705	CcSEcCtD
Diphenhydramine—Nausea—Doxorubicin—kidney cancer	7.58e-05	0.000668	CcSEcCtD
Diphenhydramine—Fentanyl—ABCB1—kidney cancer	7.37e-05	0.0178	CrCbGaD
Diphenhydramine—Phenytoin—ABCB1—kidney cancer	6.69e-05	0.0162	CrCbGaD
Diphenhydramine—Trimipramine—ABCB1—kidney cancer	5.33e-05	0.0129	CrCbGaD
Diphenhydramine—Promethazine—ABCB1—kidney cancer	5.13e-05	0.0124	CrCbGaD
Diphenhydramine—Tamoxifen—ABCB1—kidney cancer	5.1e-05	0.0123	CrCbGaD
Diphenhydramine—Doxepin—ABCB1—kidney cancer	5.08e-05	0.0123	CrCbGaD
Diphenhydramine—Methadone—ABCB1—kidney cancer	5.06e-05	0.0122	CrCbGaD
Diphenhydramine—Imipramine—ABCB1—kidney cancer	3.96e-05	0.00956	CrCbGaD
Diphenhydramine—Amitriptyline—ABCB1—kidney cancer	3.93e-05	0.0095	CrCbGaD
Diphenhydramine—SLC22A2—Metabolism—SLC2A1—kidney cancer	1.32e-05	0.000283	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—LDHB—kidney cancer	1.31e-05	0.000281	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GPC3—kidney cancer	1.3e-05	0.00028	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—LDHB—kidney cancer	1.3e-05	0.000278	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ITPR2—kidney cancer	1.29e-05	0.000277	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—BCHE—kidney cancer	1.29e-05	0.000277	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—SLC2A1—kidney cancer	1.28e-05	0.000275	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—SLC5A5—kidney cancer	1.27e-05	0.000273	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CA2—kidney cancer	1.27e-05	0.000272	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ITPR2—kidney cancer	1.26e-05	0.000271	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.26e-05	0.00027	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.24e-05	0.000267	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ITPR2—kidney cancer	1.24e-05	0.000266	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALAD—kidney cancer	1.24e-05	0.000265	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CA9—kidney cancer	1.23e-05	0.000264	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—SLC2A1—kidney cancer	1.23e-05	0.000264	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.21e-05	0.000259	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.21e-05	0.000259	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.18e-05	0.000253	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTT1—kidney cancer	1.18e-05	0.000252	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ACHE—kidney cancer	1.18e-05	0.000252	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.17e-05	0.000252	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CTNNA1—kidney cancer	1.14e-05	0.000245	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HSPB1—kidney cancer	1.14e-05	0.000244	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EIF4EBP1—kidney cancer	1.14e-05	0.000244	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CA9—kidney cancer	1.13e-05	0.000243	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PGK1—kidney cancer	1.13e-05	0.000242	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.13e-05	0.000242	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CTNNA1—kidney cancer	1.13e-05	0.000241	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CA9—kidney cancer	1.12e-05	0.000241	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EIF4EBP1—kidney cancer	1.12e-05	0.00024	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HSPB1—kidney cancer	1.12e-05	0.00024	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—SCARB1—kidney cancer	1.11e-05	0.000239	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—LDHB—kidney cancer	1.11e-05	0.000238	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS1—kidney cancer	1.1e-05	0.000236	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GSTP1—kidney cancer	1.1e-05	0.000236	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.1e-05	0.000236	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.08e-05	0.000233	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PSMD7—kidney cancer	1.08e-05	0.000232	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—POMC—kidney cancer	1.08e-05	0.000231	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GSTP1—kidney cancer	1.07e-05	0.000229	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PSMD7—kidney cancer	1.06e-05	0.000227	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ANXA1—kidney cancer	1.06e-05	0.000227	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TSC1—kidney cancer	1.06e-05	0.000227	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CRABP1—kidney cancer	1.05e-05	0.000225	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ABCB1—kidney cancer	1.04e-05	0.000224	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ANXA1—kidney cancer	1.04e-05	0.000223	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TSC1—kidney cancer	1.04e-05	0.000223	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PSMD7—kidney cancer	1.04e-05	0.000223	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GSTP1—kidney cancer	1.03e-05	0.00022	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—BCHE—kidney cancer	1.03e-05	0.00022	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FLT1—kidney cancer	1.02e-05	0.00022	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.01e-05	0.000217	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ABCB1—kidney cancer	1.01e-05	0.000217	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GSTM1—kidney cancer	1.01e-05	0.000217	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FLT1—kidney cancer	1.01e-05	0.000216	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GSTM1—kidney cancer	9.83e-06	0.000211	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—SLC2A1—kidney cancer	9.78e-06	0.00021	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ITPR2—kidney cancer	9.75e-06	0.000209	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ABCB1—kidney cancer	9.72e-06	0.000208	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—POMC—kidney cancer	9.66e-06	0.000207	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CRABP1—kidney cancer	9.65e-06	0.000207	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CA9—kidney cancer	9.61e-06	0.000206	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CYP1A1—kidney cancer	9.59e-06	0.000206	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CRABP1—kidney cancer	9.57e-06	0.000205	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—POMC—kidney cancer	9.51e-06	0.000204	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PAK1—kidney cancer	9.5e-06	0.000204	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—JUNB—kidney cancer	9.5e-06	0.000204	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GSTM1—kidney cancer	9.43e-06	0.000202	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.4e-06	0.000201	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PAK1—kidney cancer	9.35e-06	0.0002	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—JUNB—kidney cancer	9.35e-06	0.0002	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CYP1A1—kidney cancer	9.31e-06	0.0002	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.99e-06	0.000193	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ITPR2—kidney cancer	8.97e-06	0.000192	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CYP1A1—kidney cancer	8.94e-06	0.000192	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ACHE—kidney cancer	8.89e-06	0.000191	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTT1—kidney cancer	8.89e-06	0.000191	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ITPR2—kidney cancer	8.89e-06	0.000191	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—POMC—kidney cancer	8.77e-06	0.000188	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—POMC—kidney cancer	8.63e-06	0.000185	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PTGS2—kidney cancer	8.6e-06	0.000184	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SCARB1—kidney cancer	8.42e-06	0.00018	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS1—kidney cancer	8.33e-06	0.000179	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.2e-06	0.000176	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTT1—kidney cancer	8.18e-06	0.000175	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ACHE—kidney cancer	8.18e-06	0.000175	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CRABP1—kidney cancer	8.17e-06	0.000175	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PSMD7—kidney cancer	8.17e-06	0.000175	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTP1—kidney cancer	8.16e-06	0.000175	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ACHE—kidney cancer	8.11e-06	0.000174	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTT1—kidney cancer	8.11e-06	0.000174	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF2—kidney cancer	7.77e-06	0.000166	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—BCHE—kidney cancer	7.75e-06	0.000166	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SCARB1—kidney cancer	7.74e-06	0.000166	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN2B—kidney cancer	7.73e-06	0.000166	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ABCB1—kidney cancer	7.72e-06	0.000166	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SCARB1—kidney cancer	7.68e-06	0.000165	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS1—kidney cancer	7.67e-06	0.000164	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SLC5A5—kidney cancer	7.65e-06	0.000164	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.65e-06	0.000164	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF2—kidney cancer	7.64e-06	0.000164	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	7.61e-06	0.000163	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ITPR2—kidney cancer	7.6e-06	0.000163	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS1—kidney cancer	7.6e-06	0.000163	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PSMD7—kidney cancer	7.52e-06	0.000161	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF1R—kidney cancer	7.51e-06	0.000161	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTM1—kidney cancer	7.5e-06	0.000161	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PTEN—kidney cancer	7.5e-06	0.000161	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PSMD7—kidney cancer	7.45e-06	0.00016	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SLC2A1—kidney cancer	7.39e-06	0.000158	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF1R—kidney cancer	7.39e-06	0.000158	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—RAF1—kidney cancer	7.23e-06	0.000155	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.17e-06	0.000154	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—POMC—kidney cancer	7.15e-06	0.000153	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—IL2—kidney cancer	7.14e-06	0.000153	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—BCHE—kidney cancer	7.13e-06	0.000153	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—RAF1—kidney cancer	7.12e-06	0.000153	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CYP1A1—kidney cancer	7.11e-06	0.000152	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—BCHE—kidney cancer	7.06e-06	0.000151	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SLC5A5—kidney cancer	7.04e-06	0.000151	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—IL2—kidney cancer	7.03e-06	0.000151	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.01e-06	0.00015	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.98e-06	0.00015	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—POMC—kidney cancer	6.94e-06	0.000149	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTT1—kidney cancer	6.93e-06	0.000149	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ACHE—kidney cancer	6.93e-06	0.000149	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SLC2A1—kidney cancer	6.8e-06	0.000146	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.74e-06	0.000144	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—POMC—kidney cancer	6.67e-06	0.000143	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SCARB1—kidney cancer	6.56e-06	0.000141	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.54e-06	0.00014	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS1—kidney cancer	6.49e-06	0.000139	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL2—kidney cancer	6.49e-06	0.000139	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL2—kidney cancer	6.38e-06	0.000137	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PSMD7—kidney cancer	6.37e-06	0.000137	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.25e-06	0.000134	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HIF1A—kidney cancer	6.18e-06	0.000133	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TSC2—kidney cancer	6.17e-06	0.000132	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTP1—kidney cancer	6.16e-06	0.000132	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HIF1A—kidney cancer	6.08e-06	0.00013	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TSC2—kidney cancer	6.07e-06	0.00013	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—BCHE—kidney cancer	6.04e-06	0.000129	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC5A5—kidney cancer	5.96e-06	0.000128	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KDR—kidney cancer	5.91e-06	0.000127	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ABCB1—kidney cancer	5.84e-06	0.000125	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KDR—kidney cancer	5.82e-06	0.000125	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC2A1—kidney cancer	5.76e-06	0.000123	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—kidney cancer	5.71e-06	0.000122	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.7e-06	0.000122	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTP1—kidney cancer	5.67e-06	0.000122	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTM1—kidney cancer	5.66e-06	0.000121	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTP1—kidney cancer	5.62e-06	0.000121	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.59e-06	0.00012	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—kidney cancer	5.54e-06	0.000119	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APC—kidney cancer	5.45e-06	0.000117	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KIT—kidney cancer	5.45e-06	0.000117	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP1A1—kidney cancer	5.37e-06	0.000115	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ABCB1—kidney cancer	5.37e-06	0.000115	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KIT—kidney cancer	5.36e-06	0.000115	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APC—kidney cancer	5.36e-06	0.000115	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ABCB1—kidney cancer	5.32e-06	0.000114	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—kidney cancer	5.32e-06	0.000114	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—POMC—kidney cancer	5.3e-06	0.000114	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CA—kidney cancer	5.29e-06	0.000113	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—MAPK3—kidney cancer	5.21e-06	0.000112	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTM1—kidney cancer	5.21e-06	0.000112	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—POMC—kidney cancer	5.18e-06	0.000111	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTM1—kidney cancer	5.17e-06	0.000111	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	5.13e-06	0.00011	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BRAF—kidney cancer	5.12e-06	0.00011	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—POMC—kidney cancer	5.1e-06	0.000109	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BRAF—kidney cancer	5.04e-06	0.000108	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTEN—kidney cancer	4.98e-06	0.000107	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—MAPK1—kidney cancer	4.96e-06	0.000106	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.94e-06	0.000106	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.9e-06	0.000105	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	4.88e-06	0.000105	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.87e-06	0.000104	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTEN—kidney cancer	4.83e-06	0.000104	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTP1—kidney cancer	4.8e-06	0.000103	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CA—kidney cancer	4.74e-06	0.000102	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—KRAS—kidney cancer	4.69e-06	0.0001	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	4.67e-06	0.0001	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTEN—kidney cancer	4.64e-06	9.94e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—KRAS—kidney cancer	4.61e-06	9.89e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ABCB1—kidney cancer	4.55e-06	9.75e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTM1—kidney cancer	4.41e-06	9.46e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.41e-06	9.46e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	4.31e-06	9.23e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RAF1—kidney cancer	4.27e-06	9.16e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RELA—kidney cancer	4.25e-06	9.12e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	4.24e-06	9.08e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ERBB2—kidney cancer	4.23e-06	9.06e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—kidney cancer	4.23e-06	9.06e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RAF1—kidney cancer	4.21e-06	9.01e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RELA—kidney cancer	4.19e-06	8.98e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.18e-06	8.97e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MTOR—kidney cancer	4.17e-06	8.94e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ERBB2—kidney cancer	4.16e-06	8.92e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MTOR—kidney cancer	4.11e-06	8.8e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.02e-06	8.62e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—POMC—kidney cancer	4e-06	8.58e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	3.92e-06	8.39e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	3.85e-06	8.26e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL2—kidney cancer	3.83e-06	8.21e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL2—kidney cancer	3.77e-06	8.08e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCND1—kidney cancer	3.74e-06	8.01e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—JUN—kidney cancer	3.73e-06	7.99e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	3.7e-06	7.93e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTEN—kidney cancer	3.69e-06	7.9e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—POMC—kidney cancer	3.68e-06	7.9e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCND1—kidney cancer	3.68e-06	7.88e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—JUN—kidney cancer	3.67e-06	7.86e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—POMC—kidney cancer	3.65e-06	7.83e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	3.64e-06	7.8e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTEN—kidney cancer	3.61e-06	7.73e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTEN—kidney cancer	3.55e-06	7.61e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CA—kidney cancer	3.51e-06	7.53e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.44e-06	7.37e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CA—kidney cancer	3.41e-06	7.31e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CA—kidney cancer	3.27e-06	7.01e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—kidney cancer	3.26e-06	6.98e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—kidney cancer	3.2e-06	6.87e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—kidney cancer	3.19e-06	6.85e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—POMC—kidney cancer	3.12e-06	6.69e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK3—kidney cancer	3.08e-06	6.6e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK3—kidney cancer	3.03e-06	6.5e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MYC—kidney cancer	3e-06	6.42e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MYC—kidney cancer	2.95e-06	6.32e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—kidney cancer	2.94e-06	6.3e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK1—kidney cancer	2.93e-06	6.28e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—kidney cancer	2.91e-06	6.24e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK1—kidney cancer	2.88e-06	6.18e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTEN—kidney cancer	2.79e-06	5.97e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KRAS—kidney cancer	2.77e-06	5.94e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KRAS—kidney cancer	2.72e-06	5.84e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CA—kidney cancer	2.6e-06	5.57e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTEN—kidney cancer	2.56e-06	5.49e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	2.54e-06	5.45e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTEN—kidney cancer	2.54e-06	5.44e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	2.5e-06	5.37e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—kidney cancer	2.49e-06	5.33e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—kidney cancer	2.46e-06	5.28e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—kidney cancer	2.42e-06	5.19e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTEN—kidney cancer	2.17e-06	4.65e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.96e-06	4.21e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.81e-06	3.87e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.79e-06	3.84e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.53e-06	3.28e-05	CbGpPWpGaD
